期刊文献+

血清E-选择素和血清C-反应蛋白在急性冠状动脉综合征患者中的变化及意义 被引量:4

Changes of serum soluble E-selectin and CRP in patients with acute coronary syndrome
原文传递
导出
摘要 目的:观察血清E选择素、血清C反应蛋白(CRP)水平在急性冠状动脉综合征(ACS)患者中的变化,并探讨其与斑块稳定性的关系。方法:30例ACS患者(ACS组)、24例稳定型心绞痛(SAP)患者(SAP组)及30例冠状动脉造影阴性者(对照组)作为入选对象,均以酶联免疫吸附法(ELISA)检测其E选择素,免疫速率散射测浊法测定其CRP水平。结果:ACS组血清E选择素、CRP水平显著高于SAP组(P<0.01)和对照组(P<0.01)。结论:血清E选择素、CRP可能与ACS发病有关,并反映斑块的不稳定性。 Objective:To observe changes of serum levels of soluble E-selectin and C-reactive protein(CRP) in patients with acute coronary syndrome. Method: Thirty patients with acute coronary syndrome(ACS), 24 patients with stable angina pectoris(SAP), 30 controls with negative coronary angiography.We measured the serum level of soluble E-selectin by means of enzyme linked immunosorbent assay (ELISA) and CRP by ultrasensitive immunoassay ( rate nephelometry with the Beckman Immunochemistry Systems). Result:The serum levels of soluble E-selectin and CRP in the ACS group were significantly higher than those in the SAP group(P< 0.01)and controls(P< 0.01). Conclusion:E-selectin and CRP may be involved in the pathogenesis of ACS and relate to the unstability of plaques.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2005年第6期328-329,共2页 Journal of Clinical Cardiology
关键词 冠状动脉疾病 E-选择素 C-反应蛋白 Coronary disease E-selectin C-reactive protein
  • 相关文献

参考文献10

  • 1Biasucci L M, Colizzi C, Rizzello V, et al. Role of inflammation in the pathogenesis of unstable coronary artery diseases.Scand J Clin Lab Invest, 1999, 59(Suppl 230):12-22.
  • 2Ritchie M E. Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation, 1998, 98:1707-1713.
  • 3Semaan H B, Gurbel P A, Anderson J F, et al. Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease. Cardiology, 2000,93:7-10.
  • 4Filippo C, Luigi M B, Antonion B, et al. Role of inflammation in the pathogenesis of unstable coronary artery disease.Am J Cardiol, 1997, 80 (5A):10-16.
  • 5宋玮,王彬尧,王长谦,厉锦华,刘建平,谢秀兰.冠心病不同类型间斑块稳定性相关指标的比较研究[J].中华心血管病杂志,2002,30(8):480-482. 被引量:15
  • 6杨大春,朱峻,周兴文,张鑫,王卫红,张继红,曾智.冠心病炎性标志物检测的意义[J].临床心血管病杂志,2004,20(1):1-3. 被引量:31
  • 7Torzewski J, Torzewski M, Bowyer D E, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary aeteries. Arterioscler Thromb Vasc Biol,1998,18:1386-1392.
  • 8Kervinen H, Palosuo T, Manninen V, et al. Joint effects of C- reactive protein and other risk factors on acute coronary events. Am Heart J,2001,141:580-585.
  • 9Ferranti S D, Rifai N. C-reactive protein and cardiovascular disease:a review of risk prediction and interventions. Clin Chim Acta, 2002,317:1-15.
  • 10Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middleaged men:Results from the MONICA Augsburg cohort study 1984-1992. Circulation,1999,99:237-242.

二级参考文献15

  • 1Buja LM, Willerson JT. Clinicopathologic correlates of acute ischemic heart disease syndromes. Am J Cardiol,1981,47:343-356.
  • 2Van der Wal AC, Becker AE, Van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.Circulation,1994,89:36-44.
  • 3Jang YS, Lincoff AM, Plow EF, et al. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol,1994,24:1591-1601.
  • 4Lehr H, Hubner C, Nolte D, et al. Oxidatively modified human low density lipoprotein stimulates leukocyte adherence to the microvascular endotheliumin vivo. Res Exp Med,1991,191:85-90.
  • 5Kim RS, LaBella FS. Comparison of analytical methods for monitoring auto-oxidation profiles of authentic lipids. J Lipid Res,1987,28:1110-1117.
  • 6Sinikka K, Enockson C, Lopes-virella MF, et al. Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low density lipoproteins. Clin And Diagno Lab Immuno,1998,5:817-822.
  • 7Pigott R, Dillon LP, Hemingway IH, et al. Soluble form of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun,1992,187:584-589.
  • 8Palinski W, Yla-Herttuala S, Rosenfeld ME, et al. Antisera and monoclonal antibodies specific for epitopes generated during the oxidative modification of low density lipoprotein.Arteriosclerosis,1990,10:325-333.
  • 9Danial Steinberg. Lewis a conner memorial lecture-oxidative modification of LDL and atherogenesis. Circulation, 1997,95:1062-1071.
  • 10Libby P, Geng YJ, Aikawa M, et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol, 1996,7(5):330-335.

共引文献42

同被引文献29

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部